Form 4: HCA Healthcare Director Thomas F. Frist III Reports Changes in Beneficial Ownership

Thomas F. Frist III, a director at HCA Healthcare, reported changes in his beneficial ownership of the company's common stock, including acquisitions of restricted share units and indirect holdings through various entities.

Summary

• On April 29, 2025, Thomas F. Frist III, a director of HCA Healthcare, Inc., filed a Form 4 with the SEC reporting changes in his beneficial ownership of HCA common stock.
• The reported transactions include the acquisition of 1,320 shares of common stock related to restricted share units granted as part of his director compensation.
• Frist's indirect ownership is primarily through Hercules Holding II, where he holds 3,590,019.444 units.
• He also has indirect ownership through his spouse, trusts for his children, The Thomas F. Frist III 2007 Family Trust, and Frisco, Inc.
• The total number of shares deemed beneficially owned indirectly by Frist is substantial due to his affiliations with these entities.
• A Power of Attorney was granted to Will Morrow, allowing him to act on Frist's behalf in matters related to SEC filings.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting changes in beneficial ownership, which is neutral in sentiment. It provides factual information about insider transactions.

Positives

• The acquisition of restricted share units reflects ongoing director compensation and alignment with shareholder interests.

Future Outlook

The restricted share units will vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date.

Industry Context

Form 4 filings are routine disclosures for corporate insiders and provide transparency into their transactions in company stock. This filing indicates changes in the director's holdings, which can be of interest to investors.

Comparison to Industry Standards

• Tracking insider transactions is a common practice in financial analysis.
• Comparing Frist's holdings and transactions to those of other directors at HCA and similar healthcare companies (e.g., Universal Health Services, Tenet Healthcare) can provide insights into management's sentiment and alignment with shareholder value.
• Analyzing the size and frequency of these transactions relative to industry peers can reveal trends in executive compensation and ownership.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the ownership stake of a key director.
• The acquisition of shares through restricted share units aligns the director's interests with those of shareholders.

Next Steps

• The restricted share units will vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date.
• Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

Key Dates

Keywords

HCA Healthcare, Thomas F. Frist III, beneficial ownership, Form 4, director, Hercules Holding II, restricted share units, SEC filing